Eastern Shore Research Institute is a clinical research site located in Fairhope, Alabama, United States 36532.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Eastern Shore Research Institute has participated in 9 clinical trials with 8 currently active.
Therapeutic areas: Acute Decompensated Heart Failure, Primary Prevention of Atherosclerotic Cardiovascular Disease, Cardiovascular Disease.
Sponsors: Reprieve Cardiovascular, Inc, Novartis Pharmaceuticals, Amgen.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Eastern Shore Research Institute has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Eastern Shore Research Institute has 9 clinical trials on record, with 8 currently active. Their work covers Acute Decompensated Heart Failure, Primary Prevention of Atherosclerotic Cardiovascular Disease, Cardiovascular Disease.
Yes — Eastern Shore Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.